[{"NetIncomeLoss_1_Q2_USD":-22580000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":169483000.0,"Depreciation_1_Q2_USD":388000.0,"Depreciation_2_Q2_USD":839000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-29296000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":72900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1400904.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1276000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":19.5,"InterestPaidNet_2_Q2_USD":707000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":647000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InterestAndOtherIncome_1_Q2_USD":69000.0,"InterestAndOtherIncome_2_Q2_USD":141000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-69000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":73000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2482000.0,"AssetsCurrent_0_Q2_USD":477561000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":4841000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DeferredRevenue_0_Q2_USD":74884000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":24.57,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12582000.0,"ShareBasedCompensation_2_Q2_USD":9073000.0,"Assets_0_Q2_USD":528421000.0,"AdjustmentsToAdditionalPaidInCapitalOther_1_Q2_USD":80000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":217535000.0,"CommonStockSharesIssued_0_Q2_shares":48380059.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2410000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":539000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6150566.0,"LongTermDebt_0_Q2_USD":10409000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":43855420.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43472327.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8611000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":16020000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":209494000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":2091000.0,"ImpairmentOfInvestments_2_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":170350000.0,"CommonStockValue_0_Q2_USD":5000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-6338000.0,"AccountsReceivableNetCurrent_0_Q2_USD":6213000.0,"AssetsFairValueDisclosure_0_Q2_USD":498353000.0,"EarningsPerShareBasic_1_Q2_USD":-0.51,"EarningsPerShareBasic_2_Q2_USD":-1.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":17202000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":19.5,"ResearchAndDevelopmentExpense_1_Q2_USD":23286000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":43812000.0,"DeferredRevenueNoncurrent_0_Q2_USD":46189000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2557000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":498700000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-43551000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":12.74,"StockholdersEquityNoteStockSplitConversionRatio1_2_Q2_pure":0.1186,"MarketableSecuritiesCurrent_0_Q2_USD":184765000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":12361000.0,"Liabilities_0_Q2_USD":111994000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":643865000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":11230000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":281146000.0,"OtherAssetsNoncurrent_0_Q2_USD":579000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1338000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2692000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22555000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-43633000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-22580000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":9871000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1136000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1181000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":32770000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-42936000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":25000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":-82000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q2_USD":9781000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_2_Q2_USD":17207000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2340000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5175000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-43551000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":4000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6471000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6150566.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":5535000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":10054000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-22580000.0,"LiabilitiesCurrent_0_Q2_USD":44166000.0,"DeferredRevenueCurrent_0_Q2_USD":28695000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":98118000.0,"NetIncomeLoss_2_Q2_USD":-43551000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3653000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-3000.0,"ReceivablesNetCurrent_0_Q2_USD":6213000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":3000000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":175478.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.1,"LongTermDebtNoncurrent_0_Q2_USD":10409000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":705000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5437000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":282422000.0,"NonoperatingIncomeExpense_1_Q2_USD":-464000.0,"NonoperatingIncomeExpense_2_Q2_USD":-926000.0,"AccountsPayableCurrent_0_Q2_USD":4469000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":713000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":713000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":237622000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1131000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":10124000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":104224.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":360000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5228000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9073000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":9500000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":528421000.0,"PaymentsForRepurchaseOfInitialPublicOffering_2_Q2_USD":286000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.04,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":42.25,"OperatingIncomeLoss_1_Q2_USD":-22116000.0,"OperatingIncomeLoss_2_Q2_USD":-42625000.0,"OperatingExpenses_2_Q2_USD":59832000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"OperatingExpenses_1_Q2_USD":31897000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.0,"CommonStockSharesOutstanding_0_Q2_shares":48380059.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1729000.0,"MarketableSecurities_0_Q2_USD":140400.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-227374000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":971796.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6150566.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-474000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":1276000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":217604000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":12500000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1168000.0,"StockholdersEquity_0_Q2_USD":416427000.0,"OtherLiabilitiesCurrent_0_Q2_USD":243000.0,"ProfitLoss_2_Q2_USD":-43551000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.51,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":316000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1243000.0,"Ticker":"CCCC","CIK":"1662579","name":"C4 THERAPEUTICS, INC.","OfficialName":"C4 Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"459607469.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]